Take­da nabs dengue vac­cine ap­proval in Eu­rope, as trav­el, cli­mate change con­tribute to rise in cas­es

Take­da’s dengue vac­cine Qden­ga is now ap­proved in the Eu­ro­pean Union, fol­low­ing its first ap­proval this sum­mer in In­done­sia. The big­ger ques­tion though, es­pe­cial­ly for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.